211 related articles for article (PubMed ID: 22322589)
1. Safety and response to influenza vaccine in patients with systemic-onset juvenile idiopathic arthritis receiving tocilizumab.
Shinoki T; Hara R; Kaneko U; Miyamae T; Imagawa T; Mori M; Yokota S
Mod Rheumatol; 2012 Nov; 22(6):871-6. PubMed ID: 22322589
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of influenza vaccination in a prospective longitudinal study of 31 children with juvenile idiopathic arthritis.
Toplak N; Subelj V; Kveder T; Cucnik S; Prosenc K; Trampus-Bakija A; Todorovski L; Avcin T
Clin Exp Rheumatol; 2012; 30(3):436-44. PubMed ID: 22513085
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and safety of influenza vaccination in patients with juvenile idiopathic arthritis on biological therapy using the microneutralization assay.
Camacho-Lovillo MS; Bulnes-Ramos A; Goycochea-Valdivia W; Fernández-Silveira L; Núñez-Cuadros E; Neth O; Pérez-Romero P
Pediatr Rheumatol Online J; 2017 Aug; 15(1):62. PubMed ID: 28784185
[TBL] [Abstract][Full Text] [Related]
4. Longterm safety and effectiveness of the anti-interleukin 6 receptor monoclonal antibody tocilizumab in patients with systemic juvenile idiopathic arthritis in Japan.
Yokota S; Imagawa T; Mori M; Miyamae T; Takei S; Iwata N; Umebayashi H; Murata T; Miyoshi M; Tomiita M; Nishimoto N; Kishimoto T
J Rheumatol; 2014 Apr; 41(4):759-67. PubMed ID: 24634205
[TBL] [Abstract][Full Text] [Related]
5. Relapse of systemic juvenile idiopathic arthritis after influenza vaccination in a patient receiving tocilizumab.
Shimizu M; Ueno K; Yachie A
Clin Vaccine Immunol; 2012 Oct; 19(10):1700-2. PubMed ID: 22875602
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial and oxidative stress genes are differentially expressed in neutrophils of sJIA patients treated with tocilizumab: a pilot microarray study.
Omoyinmi E; Hamaoui R; Bryant A; Jiang MC; Athigapanich T; Eleftheriou D; Hubank M; Brogan P; Woo P
Pediatr Rheumatol Online J; 2016 Feb; 14(1):7. PubMed ID: 26861863
[TBL] [Abstract][Full Text] [Related]
7. Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis.
Yokota S; Miyamae T; Imagawa T; Katakura S; Kurosawa R; Mori M
Clin Rev Allergy Immunol; 2005 Jun; 28(3):231-8. PubMed ID: 16129907
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics of influenza virus infection in juvenile idiopathic arthritis patients treated with tocilizumab.
Kawada J; Kitagawa Y; Iwata N; Ito Y
Mod Rheumatol; 2013 Sep; 23(5):972-6. PubMed ID: 23070362
[TBL] [Abstract][Full Text] [Related]
9. Discrepancy between clinical and radiological responses to tocilizumab treatment in patients with systemic-onset juvenile idiopathic arthritis.
Aoki C; Inaba Y; Choe H; Kaneko U; Hara R; Miyamae T; Imagawa T; Mori M; Oba MS; Yokota S; Saito T
J Rheumatol; 2014 Jun; 41(6):1171-7. PubMed ID: 24786929
[TBL] [Abstract][Full Text] [Related]
10. Radiologic analysis of the effect of tocilizumab on hands and large joints in children with systemic juvenile idiopathic arthritis.
Inaba Y; Ozawa R; Aoki C; Imagawa T; Mori M; Hara R; Miyamae T; Saito T; Yokota S
Mod Rheumatol; 2013 Jul; 23(4):667-73. PubMed ID: 22791270
[TBL] [Abstract][Full Text] [Related]
11. Intravenous dosing of tocilizumab in patients younger than two years of age with systemic juvenile idiopathic arthritis: results from an open-label phase 1 clinical trial.
Mallalieu NL; Wimalasundera S; Hsu JC; Douglass W; Wells C; Penades IC; Cuttica R; Huppertz HI; Joos R; Kimura Y; Milojevic D; Rosenkranz M; Schikler K; Constantin T; Wouters C
Pediatr Rheumatol Online J; 2019 Aug; 17(1):57. PubMed ID: 31438986
[TBL] [Abstract][Full Text] [Related]
12. Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis.
Ruperto N; Brunner HI; Ramanan AV; Horneff G; Cuttica R; Henrickson M; Anton J; Boteanu AL; Penades IC; Minden K; Schmeling H; Hufnagel M; Weiss JE; Pardeo M; Nanda K; Roth J; Rubio-Pérez N; Hsu JC; Wimalasundera S; Wells C; Bharucha K; Douglass W; Bao M; Mallalieu NL; Martini A; Lovell D; Benedetti F;
Rheumatology (Oxford); 2021 Oct; 60(10):4568-4580. PubMed ID: 33506875
[TBL] [Abstract][Full Text] [Related]
13. Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis under Treatment with Tocilizumab.
Yokota S; Itoh Y; Morio T; Sumitomo N; Daimaru K; Minota S
J Rheumatol; 2015 Apr; 42(4):712-22. PubMed ID: 25684767
[TBL] [Abstract][Full Text] [Related]
14. Comparisons of the outcomes between early and late tocilizumab treatment in systemic juvenile idiopathic arthritis.
Pacharapakornpong T; Vallibhakara SA; Lerkvaleekul B; Vilaiyuk S
Rheumatol Int; 2017 Feb; 37(2):251-255. PubMed ID: 27798725
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of an early response-based tapering regimen of tocilizumab in children with systemic juvenile idiopathic arthritis.
Dey S; Roy D; Sinhamahapatra P; Ghosh A
Int J Rheum Dis; 2024 May; 27(5):e15196. PubMed ID: 38769886
[TBL] [Abstract][Full Text] [Related]
16. Successful use of tocilizumab in amyloidosis secondary to systemic juvenile idiopathic arthritis.
Gupta A; Bagri NK; Tripathy SK; Barwad A; Phulware RH; Hari P
Rheumatol Int; 2020 Jan; 40(1):153-159. PubMed ID: 31273457
[TBL] [Abstract][Full Text] [Related]
17. IL-6 blockers in systemic onset juvenile idiopathic arthritis.
Barone P; Pignataro R; Garozzo MT; Leonardi S
Immunotherapy; 2016; 8(1):79-87. PubMed ID: 26642378
[TBL] [Abstract][Full Text] [Related]
18. Improvement of reduced serum cartilage oligomeric matrix protein levels in systemic juvenile idiopathic arthritis patients treated with the anti-interleukin-6 receptor monoclonal antibody tocilizumab.
Nakajima S; Naruto T; Miyamae T; Imagawa T; Mori M; Nishimaki S; Yokota S
Mod Rheumatol; 2009; 19(1):42-6. PubMed ID: 18726067
[TBL] [Abstract][Full Text] [Related]
19. Tocilizumab may slow radiographic progression in patients with systemic or polyarticular-course juvenile idiopathic arthritis: post hoc radiographic analysis from two randomized controlled trials.
Malattia C; Ruperto N; Pederzoli S; Palmisani E; Pistorio A; Wouters C; Dolezalova P; Flato B; Garay S; Giancane G; Wells C; Douglass W; Brunner HI; De Benedetti F; Ravelli A;
Arthritis Res Ther; 2020 Sep; 22(1):211. PubMed ID: 32912276
[TBL] [Abstract][Full Text] [Related]
20. Clinical improvement of renal amyloidosis in a patient with systemic-onset juvenile idiopathic arthritis who received tocilizumab treatment: a case report and literature review.
Chantarogh S; Vilaiyuk S; Tim-Aroon T; Worawichawong S
BMC Nephrol; 2017 May; 18(1):159. PubMed ID: 28499374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
